Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Thrombocytopathy

imatinib mesylate has been researched along with Thrombocytopathy in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chauhan, R; Harankhedkar, S; Mahapatra, M; Nair, RR; Saxena, R1
Cortes, J; Han, X; Kantarjian, H; Quintás-Cardama, A1
Friedhuber, A; Grigg, A; Ng, AP; Servadei, P; Tuckfield, A1

Other Studies

3 other study(ies) available for imatinib mesylate and Thrombocytopathy

ArticleYear
Imatinib-induced platelet dysfunction and hypofibrinogenemia in chronic myeloid leukemia.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2019, Volume: 30, Issue:5

    Topics: Afibrinogenemia; Blood Platelet Disorders; Hemorrhage; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Protein Kinase Inhibitors; Pyrimidines

2019
Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemia.
    Blood, 2009, Jul-09, Volume: 114, Issue:2

    Topics: Benzamides; Blood Coagulation; Blood Platelet Disorders; Dasatinib; Health; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Platelet Aggregation; Protein Kinase Inhibitors; Pyrimidines; Thiazoles

2009
Resolution of platelet function defects with imatinib therapy in a patient with chronic myeloid leukaemia in chronic phase.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2009, Volume: 20, Issue:1

    Topics: Adult; Antineoplastic Agents; Benzamides; Blood Platelet Disorders; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Platelet Function Tests; Pyrimidines

2009